Home › Free Stock Grades › CRMD
CorMedix Inc. (CRMD) Stock Grade
CRMD · Healthcare
A+
Market Cap
$837.8M
P/E Ratio
5.1
Revenue Growth (YoY)
+617.0%
Net Margin
52.3%
Return on Equity
40.2%
Dividend Yield
None
About CorMedix Inc.'s fundamentals
CorMedix is a small-cap biotechnology company with a market capitalization of $837.8 million that is currently profitable, posting a net margin of 52.3% and a return on equity of 40.2%. The company has experienced exceptional revenue growth of 617% year-over-year, though this is being valued at a relatively modest P/E ratio of 5.1. The company does not currently pay a dividend. These metrics suggest a rapidly growing biotech firm with strong profitability, though investors should note that biotech companies often experience volatile performance and high execution risk.